269 related articles for article (PubMed ID: 12660644)
1. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer.
Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Ojima T; Yamaue H
Surgery; 2003 Mar; 133(3):309-17. PubMed ID: 12660644
[TBL] [Abstract][Full Text] [Related]
2. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
[TBL] [Abstract][Full Text] [Related]
3. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
[TBL] [Abstract][Full Text] [Related]
4. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice.
Gnant MF; Puhlmann M; Alexander HR; Bartlett DL
Cancer Res; 1999 Jul; 59(14):3396-403. PubMed ID: 10416601
[TBL] [Abstract][Full Text] [Related]
5. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
Topf N; Worgall S; Hackett NR; Crystal RG
Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575
[TBL] [Abstract][Full Text] [Related]
6. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
Kijima T; Osaki T; Nishino K; Kumagai T; Funakoshi T; Goto H; Tachibana I; Tanio Y; Kishimoto T
Cancer Res; 1999 Oct; 59(19):4906-11. PubMed ID: 10519403
[TBL] [Abstract][Full Text] [Related]
7. [Experimental study on human pancreatic carcinoma treated by cytosine deaminase gene therapy].
Zhang S; Yuan S
Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):249-51. PubMed ID: 11798763
[TBL] [Abstract][Full Text] [Related]
8. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
9. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
Chung-Faye GA; Chen MJ; Green NK; Burton A; Anderson D; Mautner V; Searle PF; Kerr DJ
Gene Ther; 2001 Oct; 8(20):1547-54. PubMed ID: 11704815
[TBL] [Abstract][Full Text] [Related]
10. Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases.
Humphreys MJ; Ghaneh P; Greenhalf W; Campbell F; Clayton TM; Everett P; Huber BE; Richards CA; Ford MJ; Neoptolemos JP
Gene Ther; 2001 Aug; 8(16):1241-7. PubMed ID: 11509957
[TBL] [Abstract][Full Text] [Related]
11. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
[TBL] [Abstract][Full Text] [Related]
12. Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter.
Cao G; Kuriyama S; Gao J; Kikukawa M; Cui L; Nakatani T; Zhang X; Tsujinoue H; Pan X; Fukui H; Qi Z
Gene Ther; 1999 Jan; 6(1):83-90. PubMed ID: 10341879
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific chemo-radio-gene therapy for colorectal cancer cells using adenovirus vector expressing the cytosine deaminase gene.
Ueno M; Koyama F; Yamada Y; Fujimoto H; Takayama T; Kamada K; Naito A; Hirao S; Mukogawa T; Hamada H; Nakajima Y
Anticancer Res; 2001; 21(4A):2601-8. PubMed ID: 11724328
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.
Anello R; Cohen S; Atkinson G; Hall SJ
J Urol; 2000 Dec; 164(6):2173-7. PubMed ID: 11061950
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
[TBL] [Abstract][Full Text] [Related]
16. Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model.
Zhang M; Li S; Nyati MK; DeRemer S; Parsels J; Rehemtulla A; Ensminger WD; Lawrence TS
Cancer Res; 2003 Feb; 63(3):658-63. PubMed ID: 12566311
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
18. In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma.
Lan KH; Kanai F; Shiratori Y; Ohashi M; Tanaka T; Okudaira T; Yoshida Y; Hamada H; Omata M
Cancer Res; 1997 Oct; 57(19):4279-84. PubMed ID: 9331089
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach.
Anderson LM; Krotz S; Weitzman SA; Thimmapaya B
Cancer Gene Ther; 2000 Jun; 7(6):845-52. PubMed ID: 10880014
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice.
Cao X; Ju DW; Tao Q; Wang J; Wan T; Wang BM; Zhang W; Hamada H
Gene Ther; 1998 Aug; 5(8):1130-6. PubMed ID: 10326037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
